NAMPT Inhibitors Market

The NAMPT inhibitors market involves the development of new therapies that target cellular energy metabolism for cancer treatment. These drugs inhibit the NAMPT enzyme, a key component in the NAD+ biosynthesis pathway, to limit energy supply to tumor cells. The primary customers are pharmaceutical and biotechnology companies. Key growth drivers include a strong focus on novel oncology treatments, ongoing clinical and preclinical research, and supportive regulatory pathways for targeted drugs.